Regulatory exclusivity shield context
Portfolio and BD teams use this context to model protection runway, challenge pressure, and loss-of-exclusivity timing.
All FDA exclusivity codes (NCE, ODE, PED, NDF, etc.) with expiry dates. Exclusivity shield analysis for IRA eligibility assessment.
Request context access
Ask us to provision this analytical context into your BigQuery or Snowflake workspace.
Request AccessRelated context
Overview
Portfolio and BD teams use this context to model protection runway, challenge pressure, and loss-of-exclusivity timing.
All FDA exclusivity codes (NCE, ODE, PED, NDF, etc.) with expiry dates. Exclusivity shield analysis for IRA eligibility assessment.
Build patent cliff and loss-of-exclusivity timelines using normalized patent, exclusivity, and approval identifiers.
Compare FDA-listed patents with USPTO metadata, assignee networks, and forward citation context.
Separate substance, product, and method-of-use protection when modeling generic or biosimilar entry.
Join IP records to revenue, labels, clinical stage, and target biology through the drug identity spine.
Source authority
FDA Orange Book Exclusivity Files
Freshness
Last refreshed 2026-09-01
Monthly
Coverage
8K+ exclusivity entries
2 delivery tables
